logo
logo

AI-Powered Startup Actnova Secures $ 2.4 million in Pre-Series A Funding for Breakthrough Animal Behavior Testing Solution - KoreaTechDesk

Feb 07, 2024over 1 year ago

Amount Raised

$2.4 Million

Round Type

seed

SeoulInformation TechnologyMachine LearningArtificial IntelligenceBiotechnologyHealth Care

Investors

Fast VenturesA VenturesHana Ventures

Description

Actnova, led by CEO Kim Dae-geon, has secured a $2.4-million Pre-Series A round investment spearheaded by Hana Ventures with contributions from A Ventures and Fast Ventures. The investment underscores Actnova’s growing prominence in animal behavior testing, and its expansion into prestigious institutions such as MIT and the Broad Institute. The company's collaboration with esteemed organizations like the Korea Brain Research Institute and Daegu Cheombok Preclinical Center has further validated its technology and products in real-world research settings.

Company Information

Company

Actnova

Location

Seoul, Seoul, South Korea

About

Actnova is a Korean startup specializing in AI-powered animal behavior testing solutions, particularly in drug development for brain diseases like dementia and Parkinson’s disease. The company's core strength lies in its AI SaaS solution, Actverse, which analyzes behavioral symptom tests in animal models.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Related People